2/3
08:00 am
inab
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
Low
Report
IN8bio to Present at Upcoming Investor and Scientific Conferences in February
1/24
05:08 am
inab
IN8bio (NASDAQ:INAB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
Medium
Report
IN8bio (NASDAQ:INAB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings .
1/17
06:56 am
inab
IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research to a "hold" rating.
Medium
Report
IN8bio (NASDAQ:INAB) was upgraded by analysts at Zacks Research to a "hold" rating.
1/12
08:55 am
inab
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma [Yahoo! Finance]
Medium
Report
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma [Yahoo! Finance]
1/12
08:00 am
inab
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
High
Report
IN8bio Presents Updated Phase I/II Data Demonstrating Meaningful and Durable Survival Improvements in Newly Diagnosed Glioblastoma
12/19
08:35 am
inab
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager [Yahoo! Finance]
High
Report
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager [Yahoo! Finance]
12/19
08:00 am
inab
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
High
Report
IN8bio Announces Pricing of Private Placement of up to $40.2 Million to Advance Novel Gamma-Delta T Cell Engager
5/7/2025
04:00 pm
inab
in8bio, inc.
MISS
Report
2.1%
in8bio, inc.
3/13/2025
04:05 pm
inab
in8bio, inc.
MISS
Report
-0.4%
in8bio, inc.
3/13/2025
04:05 pm
inab
in8bio, inc.
MISS
Report
-0.4%
in8bio, inc.
3/13/2025
04:05 pm
inab
in8bio, inc.
MISS
Report
-0.4%
in8bio, inc.
1/30
04:31 pm
inab
Form 424B3 IN8BIO, INC.
Medium
Report
Form 424B3 IN8BIO, INC.
1/29
03:48 pm
inab
Form SCHEDULE 13G IN8BIO, INC. Filed by: FRANKLIN RESOURCES INC
Neutral
Report
Form SCHEDULE 13G IN8BIO, INC. Filed by: FRANKLIN RESOURCES INC
1/29
06:06 am
inab
Form EFFECT IN8BIO, INC.
Low
Report
Form EFFECT IN8BIO, INC.
1/20
04:55 pm
inab
Form S-3 IN8BIO, INC.
Low
Report
Form S-3 IN8BIO, INC.
1/2
07:10 pm
inab
Form SCHEDULE 13D IN8BIO, INC. Filed by: FAIRBAIRN EMILY
Low
Report
Form SCHEDULE 13D IN8BIO, INC. Filed by: FAIRBAIRN EMILY
12/30
04:23 pm
inab
Form D IN8BIO, INC.
Low
Report
Form D IN8BIO, INC.
12/30
01:56 pm
inab
Form SCHEDULE 13G IN8BIO, INC. Filed by: 683 Capital Management, LLC
Medium
Report
Form SCHEDULE 13G IN8BIO, INC. Filed by: 683 Capital Management, LLC
12/29
04:01 pm
inab
Form SCHEDULE 13D/A IN8BIO, INC. Filed by: BIOS Fund II, LP
High
Report
Form SCHEDULE 13D/A IN8BIO, INC. Filed by: BIOS Fund II, LP
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register